SYM Financial Corp’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$437K Sell
777
-64
-8% -$41K 0.04% 153
2025
Q4
$569K Sell
841
-36
-4% -$24.5K 0.06% 112
2025
Q3
$560K Sell
877
-967
-52% -$587K 0.06% 103
2025
Q2
$989K Sell
1,844
-36
-2% -$17.2K 0.11% 61
2025
Q1
$790K Buy
1,880
+543
+41% +$236K 0.1% 61
2024
Q4
$553K Buy
+1,337
New +$586K 0.07% 85

Other funds holding IDXX

SYM Financial Corp's IDXX Position: Q1 2026 in Review

SYM Financial Corp reduced its Idexx Laboratories (IDXX) stake by 7.6% in Q1 2026, selling an estimated $41K and leaving 777 shares worth $437K. The position accounts for 0.04% of the portfolio, ranked #153.

SYM Financial Corp first reported a position in IDXX in Q4 2024 and has held it in 6 quarters since. The position peaked at $989K in Q2 2025. 1,312 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • SYM Financial Corp held 777 shares of Idexx Laboratories worth $437K as of Q1 2026.
  • SYM Financial Corp sold 64 Idexx Laboratories shares in Q1 2026, an estimated $41K.
  • Idexx Laboratories made up 0.04% of SYM Financial Corp's portfolio in Q1 2026, its #153 holding.
  • SYM Financial Corp first reported a position in Idexx Laboratories in Q4 2024 and has held it in 6 quarters since.
  • SYM Financial Corp's Idexx Laboratories position peaked at $989K in Q2 2025.
  • 1,312 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on SYM Financial Corp's 13F filing for Q1 2026, filed 8 May 2026.